With support of Granite Equity Partners, MicroBioLogics says it has reinforced its position as a producer of reference stock cultures for quality control microbiology and clinical diagnostic testing
MicroBioLogics has announced ar new relationship with investment group Granite Equity Partners.
Granite Equity Partners is a Minnesota based private equity firm focused on buyouts, recapitalisations and growth equity investments.
The partners of Granite Equity have accumulated over four decades of experience and management expertise which will play a major role in the future growth and international expansion of MicroBioLogics.
Chief executive officer Robert Coborn states, "MicroBioLogics is a true global leader in our market niche.
"This new year brings many exciting opportunities to MicroBioLogics.
"In early 2008 we introduced the MicroBioLogics License and Supply Programme.
"We are currently in the final stages of receiving ISO 17025:2005 accreditation, and we continue to add international distribution partners to our commercial network.
"Granite Equity Partners will help us achieve our ambitious growth plans".
In this next phase of the company's growth, two partners from Granite Equity will join MicroBioLogics as members of the board of directors.
Their unique backgrounds with strong science and business leadership experience make them well suited to assist MicroBioLogics in facilitating growth and development strategies.
Granite Equity Partners co-founder and partner Patrick Edeburn says: "MicroBioLogics is a strong company with a lot of potential for growth.
"We are happy to have this opportunity and look forward to a long-term partnership with them".
Coborn adds: "We chose to work with Granite Equity Partners because they share our commitment to making a positive impact in our community and preserving the longstanding relationships we have built with our loyal employees".
"I am certain this relationship will give MicroBioLogics the means to realise its full potential."
